Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN PROPANEDIOL Cause Fall? 181 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Fall have been filed in association with DAPAGLIFLOZIN PROPANEDIOL (FARXIGA). This represents 1.1% of all adverse event reports for DAPAGLIFLOZIN PROPANEDIOL.

181
Reports of Fall with DAPAGLIFLOZIN PROPANEDIOL
1.1%
of all DAPAGLIFLOZIN PROPANEDIOL reports
17
Deaths
86
Hospitalizations

How Dangerous Is Fall From DAPAGLIFLOZIN PROPANEDIOL?

Of the 181 reports, 17 (9.4%) resulted in death, 86 (47.5%) required hospitalization, and 6 (3.3%) were considered life-threatening.

Is Fall Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN PROPANEDIOL. However, 181 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN PROPANEDIOL Cause?

Death (3,443) Fungal infection (1,204) Blood glucose increased (778) Weight decreased (777) Urinary tract infection (583) Dizziness (582) Diabetic ketoacidosis (547) Nausea (460) Fatigue (442) Pollakiuria (388)

What Other Drugs Cause Fall?

ADALIMUMAB (11,399) CARBIDOPA\LEVODOPA (7,132) LENALIDOMIDE (6,229) ETANERCEPT (5,839) DALFAMPRIDINE (5,554) APIXABAN (5,063) METHOTREXATE (4,250) DIMETHYL (4,208) TOFACITINIB (4,064) PREGABALIN (4,047)

Which DAPAGLIFLOZIN PROPANEDIOL Alternatives Have Lower Fall Risk?

DAPAGLIFLOZIN PROPANEDIOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN PROPANEDIOL vs DAPRODUSTAT DAPAGLIFLOZIN PROPANEDIOL vs DAPSONE DAPAGLIFLOZIN PROPANEDIOL vs DAPTOMYCIN DAPAGLIFLOZIN PROPANEDIOL vs DARATUMUMAB

Related Pages

DAPAGLIFLOZIN PROPANEDIOL Full Profile All Fall Reports All Drugs Causing Fall DAPAGLIFLOZIN PROPANEDIOL Demographics